Research, Charts & Company Announcements
Research Tree provides access to ongoing research coverage, media content and regulatory news on ANDES ENERGIA PLC. We currently have 6 research reports from 1 professional analysts.
|09Nov16 03:12||RNS||Holding(s) in Company|
|21Oct16 03:23||RNS||Stmnt re Share Price Movement|
|19Sep16 07:01||RNS||Directorate Change|
|19Sep16 07:00||RNS||Half-year Report|
|25Aug16 07:00||RNS||Operational update|
|01Aug16 07:00||RNS||Group Production Update|
|30Jun16 04:28||RNS||Result of AGM|
Frequency of research reports
Research reports on
ANDES ENERGIA PLC
ANDES ENERGIA PLC
Solid interim results
19 Sep 16
We reiterate our Buy rating on Andes Energia and 50p target price following a solid set of interim results which demonstrate the progress that it is making with its Chachahuen assets and the growth in EBITDA that these assets deliver. The business environment in Argentina is improving, as are relations with the UK, and this should help Andes potentially start to realise some value from its extensive Vaca Muerta acreage, where it has 250,000 net mineral acres. Andes continues to trade at a steep discount to our core NAV of 24p.
FY15 results highlight operational progress
24 May 16
We reiterate our Buy rating on Andes Energia following 2015 operating and financial results that demonstrate a strong performance in what has been a very weak environment for the oil and gas sector. We expect that strong production growth in Chachahuen will be key in almost trebling EBITDA by 2018, relative to 2015. With investor sentiment toward Argentina improving, we highlight that Andes is trading at a 24% discount to our core NAV of 24.4p which itself attributes no value to its 250,000 net acres in the Vaca Muerta.
Oil & Gas - A turning point for the E&P sector
28 Oct 15
We suggest that, following 4½ years of underperformance, the E&P sector is set for a sharp recovery relative to the market. We think that this will be driven by a dramatic reversal in E&P margins, as a recovery in oil prices coincides with reductions in upstream costs, similar to what happened in 2003/04 (following the consolidation of the majors) and 2009/10 (post the financial crisis). We focus our stock recommendations on our corporate clients – Andes Energia, Nighthawk Energy and Oilex - but acknowledge that the entire sector should participate in the recovery.
Growing production at $70/bbl oil prices
06 Oct 15
We reiterate our Buy rating and retain our 93p target price following Andes Energia’s interim results. Andes benefits from high domestic oil prices in Argentina, production has grown over 20% yoy in Argentina and the company is now funded to fully participate in the aggressive drilling campaign in the conventional Chachahuen oilfield, operated by YPF. Andes is trading at a 32% discount to our core NAV of 34p, which includes just production and development assets, the majority of which are in Argentina.
30 Nov 16
Abzena (ABZA): Interim results indicate happy customers (BUY) | Horizonte Minerals* (HZM): Fund raise completed (CORP) | SacOil* (SAC): Half-year trading statement (CORP) | Revolution Bars (RBG): New openings (BUY) | Amino Technologies* (AMO): Multi operator FUSION roll out (CORP)
Small Cap Breakfast
29 Nov 16
Asia Pacific Investment Partner - the research-driven emerging and frontier markets real estate development business intends to float on AIM and conduct a placing in December RM Secured Direct Lending - The secured direct lending fund intends to float on the Main Market on 15 December raising up to £100m Diversified Oil & Gas— Schedule One now out. $60m to be raised. Expected admission 6 December. Creo Medical Group —UK based medical device company focused on surgical endoscopy, a recent development in minimally invasive surgery. Admission due 7 December. Fundraising details TBA.
GTL transaction not going ahead
01 Dec 16
Intelligent Energy (IEH) has announced that the deal to acquire the Energy Management Business of GTL will not now be consummated. The move leaves management free to concentrate on driving sales of commercially ready B2B products, which is a key element of its strategy. We adjust our FY17e revenue estimate while leaving our pre-exceptional losses and cash-flow forecasts unchanged.
01 Nov 16
Since our last outlook note, Quadrise has begun to supply MSAR for extended LONO sea trials, paving the way for commercial adoption from calendar H217 onwards. In August it signed a memorandum of understanding with clients in the Kingdom of Saudi Arabia (KSA), which is a key enabler for progressing the production-to-combustion pilot there. In October it completed a placing and open offer raising a total of £5.25m (gross). This should enable it to transition comfortably to the commercial phase on successful completion of the LONO and KSA trials.